IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 189 filers reported holding IMMUNOGEN INC in Q3 2019. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $71,000 | -25.3% | 10,815 | -7.8% | 0.00% | – |
| Q1 2021 | $95,000 | -6.9% | 11,729 | -58.6% | 0.00% | – |
| Q3 2020 | $102,000 | -86.9% | 28,351 | -83.3% | 0.00% | -100.0% |
| Q2 2020 | $781,000 | +197.0% | 169,936 | +120.4% | 0.00% | +50.0% |
| Q1 2020 | $263,000 | -71.0% | 77,093 | -56.7% | 0.00% | -50.0% |
| Q4 2019 | $908,000 | +97.8% | 177,855 | -6.1% | 0.00% | +100.0% |
| Q3 2019 | $459,000 | +1380.6% | 189,497 | +4311.0% | 0.00% | – |
| Q2 2017 | $31,000 | -73.5% | 4,296 | -85.8% | 0.00% | -100.0% |
| Q1 2017 | $117,000 | +53.9% | 30,327 | +23.1% | 0.00% | – |
| Q2 2016 | $76,000 | – | 24,637 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |